Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ciliary microtubule inner protein 4 (CIMIP4) is a protein encoded in humans (gene symbol: CIMIP4; previous/secondary symbols: C22orf33, TEX33, EAN57)[6][4]. It belongs to the class of microtubule inner proteins found in the luminal meshwork inside the microtubule cylinder of cilia and flagella, primarily contributing to the structural integrity and stability of these organelles[5]. CIMIP4's strongest gene expression and predicted localization are in the sperm flagellum[6][4]. It is not essential for spermiogenesis or male fertility, and knockout models show no overt phenotype in sperm development[6]. No evidence suggests CIMIP4 plays a direct role in signal transduction, enzymatic activity, or as a druggable therapeutic target. However, mutations or structural changes in ciliary and microtubule inner proteins as a group can contribute to human diseases of microtubule or cilia dysfunction, such as primary ciliary dyskinesia or motility-related disorders[1][5][7]. CIMIP4 does not have known drug interactors or biomarker relevance at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliary microtubule inner protein 4 (CIMIP4).